DRMAW icon

Dermata Therapeutics (DRMAW)

NAS

$0.014

$0.00 (

0.00%

)

1D
5D
1M
6M
1Y
5Y
Market closed

DRMAW: $0.014 / ₿ 0 BTC / 13 Sats

-$0.100$0.100$0.30$0.50$0.70$0.90$1.10
1D
5D
1M
6M
1Y
5Y

Last updated January 1st, 1970 at 12:00AM. Log in now to access real-time pricing data.

Key statistics

$0.014
$0.0070 - $0.044
$172.00
$0.016 - $0.025
No

What is Dermata Therapeutics (DRMAW)?

Dermata Therapeutics Inc is a late-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications. Its two product candidates, XYNGARI (formerly known as DMT310) and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases. Dermata announced positive Phase 3 data from its STAR-1 clinical trial in March 2025.

The Dermata Therapeutics (DRMAW) stock price has been falling

The Dermata Therapeutics, Inc. Warrant (DRMAW) stock price today is $0.014, reflecting a 0.00% move since the market opened. The company’s market capitalization stands at , with a daily trading volume of $172.00 shares. The previous closing price was $0.014.

How to buy Dermata Therapeutics (DRMAW)

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy DRMAW

Search for DRMAW in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy DRMAW.

DRMAW FAQs

DRMAW is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

DRMAW is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Dermata Therapeutics, Inc. Warrant (DRMAW) has traded between a low of $0.0070 and a high of $0.044.

DRMAW is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Dermata Therapeutics? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
DRMAW icon
DRMAW

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy Dermata Therapeutics in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

IMNN icon

IMNN

VMCWF icon

Top losers

Compare the worst-performing stocks of 
the day

WTO icon

WTO

MAPSW icon

MAPSW

QVCGP icon

QVCGP

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.